{"count":4,"index":{"built_at":"2026-07-27T16:37:17.943683+00:00","public_records":55311,"revision":"4d583ee400e1200c2937dbe3"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: CYP2D6 in the context of Allergie"},"results":[{"answer":"CYP2D6 is a key drug-metabolizing enzyme involved in the breakdown of many medications, including some antihistamines and other allergy drugs. However, the provided context contains no specific studies or data linking CYP2D6 variants directly to allergy risk or severity. The evidence level is therefore mechanistic/unclear: plausible biochemical pathways exist (e.g., altered metabolism of anti-allergy drugs), but no robust human studies confirm a clinically relevant association with allergy phenotypes. DTC genetic tests marketing CYP2D6 in the allergy context often overstate its significance. A DNA test cannot replace allergy diagnosis or management; blood levels and physician oversight are essential. Safety note: CYP2D6 phenotypes (poor, intermediate, extensive, ultrarapid metabolizer) can affect efficacy and side effects of allergy medications – this should be addressed through clinical pharmacogenetic counseling, not via direct-to-consumer testing.","area":"gesundheit","canonical_id":"gesundheit:canonical-47c630ba614514a714873e4f","id":"public-8ef2c65c533ab542654cb86e","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP2D6 in the context of Allergie","score":22.19150417,"snippet":"CYP2D6 is a key drug-metabolizing enzyme involved in the breakdown of many medications, including some antihistamines and other allergy drugs. However, the provided context contains no specific studies or data linking CYP2D6 variants directly to allergy risk or severity. The evidence level is therefore mechanistic/unclear: plausible biochemical pathways exist (e.g., altered metabolism of anti-allergy drugs), but no robust human studies confirm a clinically relevant association with allergy phenotypes. DTC genetic tests marketing CYP2D6 in the allergy context often overstate its significance. A DNA test cannot replace allergy diagnosis or management; blood levels and physician oversight are e","sources":[],"title":"Evidence check: CYP2D6 in the context of Allergie","url":"https://tikki.wiki/wissen/gesundheit/frage/public-8ef2c65c533ab542654cb86e/evidence-check-cyp2d6-in-the-context-of-allergie/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The provided context contains no information on CYP2D6 in relation to allergy. CYP2D6 is a well-studied drug-metabolizing enzyme (phase I) that influences the metabolism of many medications, including some antihistamines and corticosteroids used for allergies. However, there is no strong evidence that CYP2D6 variants directly determine allergy risk or sensitization. The association is purely pharmacogenetic: individuals with different CYP2D6 phenotypes (poor, intermediate, extensive, ultrarapid metabolizers) may experience altered drug levels, efficacy, or side effects of allergy medications. Evidence is mechanistic and supported by clinical pharmacokinetic studies, but not validated for allergy diagnosis or prevention. MyBody-X currently does not offer a specific CYP2D6 test. A CYP2D6 genetic test can aid personalized drug selection, but it does not replace standard allergy workup (skin tests, IgE). Caution: interpretation requires medical supervision, as dose adjustments are only meaningful in a clinical context. Evidence: mechanistic/unclear.","area":"gesundheit","canonical_id":"gesundheit:canonical-e7b6e539c2c4622e8c80edd2","id":"public-a472970acf87d3e1eb1cfa40","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP2D6 in the context of allergy","score":21.34950348,"snippet":"The provided context contains no information on CYP2D6 in relation to allergy. CYP2D6 is a well-studied drug-metabolizing enzyme (phase I) that influences the metabolism of many medications, including some antihistamines and corticosteroids used for allergies. However, there is no strong evidence that CYP2D6 variants directly determine allergy risk or sensitization. The association is purely pharmacogenetic: individuals with different CYP2D6 phenotypes (poor, intermediate, extensive, ultrarapid metabolizers) may experience altered drug levels, efficacy, or side effects of allergy medications. Evidence is mechanistic and supported by clinical pharmacokinetic studies, but not validated for all","sources":[],"title":"Evidence check: CYP2D6 in the context of allergy","url":"https://tikki.wiki/wissen/gesundheit/frage/public-a472970acf87d3e1eb1cfa40/evidence-check-cyp2d6-in-the-context-of-allergy/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The query concerns the 'Pharmakogenetik Medicheck' in the context of allergies. The provided knowledge contexts contain no specific information on this test or pharmacogenetics for allergy medications. Pharmacogenetic testing for allergies is not well established; most allergy drugs (antihistamines, corticosteroids) are metabolized by multiple enzymes and transporters with limited clinically relevant gene variants. Known examples like CYP2D6 for codeine (rarely used in allergies) or HLA typing for abacavir do not directly apply to common allergy drugs. Direct-to-consumer tests like Medicheck may report associations, but these are often insufficiently validated. Without specific study data from the context, the evidence is unclear. Medical consultation before changing therapy is essential.","area":"gesundheit","canonical_id":"gesundheit:canonical-9030a5d247efb0da25b6f860","id":"public-9bcd434c5340d28a9197e56d","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of allergy","score":20.28725563,"snippet":"The query concerns the 'Pharmakogenetik Medicheck' in the context of allergies. The provided knowledge contexts contain no specific information on this test or pharmacogenetics for allergy medications. Pharmacogenetic testing for allergies is not well established; most allergy drugs (antihistamines, corticosteroids) are metabolized by multiple enzymes and transporters with limited clinically relevant gene variants. Known examples like CYP2D6 for codeine (rarely used in allergies) or HLA typing for abacavir do not directly apply to common allergy drugs. Direct-to-consumer tests like Medicheck may report associations, but these are often insufficiently validated. Without specific study data fr","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of allergy","url":"https://tikki.wiki/wissen/gesundheit/frage/public-9bcd434c5340d28a9197e56d/evidence-check-pharmakogenetik-medicheck-in-the-context-of-allergy/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"DNA metabolism tests (e.g., CYP1A2, CYP2D6) analyze enzymes that process drugs or dietary compounds. A direct link to allergies is not scientifically established. Allergies are primarily driven by immune reactions to allergens, involving genes like HNMT (histamine breakdown) or HLA complexes – which are not covered by typical metabolism tests. The provided context sources contain no studies connecting CYP1A2/metabolic genes to allergy risk. DTC providers often overstate clinical relevance. For allergies, established methods such as IgE testing, skin prick tests, and clinical history are essential. A DNA metabolism test may support personalized nutrition or medication choices but does not replace allergological workup. Evidence: unclear, as no direct human studies are in context.","area":"gesundheit","canonical_id":"gesundheit:canonical-1974aeaecd211ea85acc7e74","id":"public-c63971c5aeb94e7297fffb05","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: DNA Stoffwechseltest in the context of allergy","score":20.19781814,"snippet":"DNA metabolism tests (e.g., CYP1A2, CYP2D6) analyze enzymes that process drugs or dietary compounds. A direct link to allergies is not scientifically established. Allergies are primarily driven by immune reactions to allergens, involving genes like HNMT (histamine breakdown) or HLA complexes – which are not covered by typical metabolism tests. The provided context sources contain no studies connecting CYP1A2/metabolic genes to allergy risk. DTC providers often overstate clinical relevance. For allergies, established methods such as IgE testing, skin prick tests, and clinical history are essential. A DNA metabolism test may support personalized nutrition or medication choices but does not rep","sources":[],"title":"Evidence check: DNA Stoffwechseltest in the context of allergy","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c63971c5aeb94e7297fffb05/evidence-check-dna-stoffwechseltest-in-the-context-of-allergy/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}